6:00 PM
 | 
Feb 28, 2007
 |  BC Extra  |  Clinical News

Genitope down on MyVax data

GTOP fell $0.52 (13%) to $3.49 on 1.2 million shares on Wednesday as investors digested another conference call in which the company discussed blinded Phase III data for MyVax...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >